Roquette Executive and Leadership Team

Armand Chen, the Roquette Chief Operating Officer and Qualicaps Chief Executive Officer at Roquette, directs global manufacturing excellence and operational efficiency across all plant-based ingredient facilities. Overseeing the integration of Qualicaps into the broader corporate portfolio, the Chief Operating Officer ensures seamless alignment between pharmaceutical excipient production and food-grade manufacturing standards. This leadership role demands rigorous oversight of supply chain logistics and production scalability to meet rising demand for sustainable bio-based materials. By optimizing industrial processes, Armand Chen drives significant improvements in resource utilization and output quality. The Chief Operating Officer maintains constant communication with the Board to refine long-term manufacturing strategies. Through the implementation of advanced automation and sustainable processing techniques, the Chief Operating Officer secures the competitive position of the company within the global health and nutrition markets, ensuring consistent delivery of high-performance solutions to international clients.

Brendon Boland, the Chief Financial Officer at Roquette, manages the entire global financial architecture, including capital allocation, fiscal planning, and corporate investment strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures that all business units maintain strict adherence to budgetary targets and long-term growth objectives. This role involves coordinating with executive leadership to evaluate potential acquisitions and expansion opportunities within the bio-based industry. By implementing robust financial reporting systems, Brendon Boland provides the transparency necessary for informed decision-making at the highest levels. The Chief Financial Officer monitors global market trends to mitigate economic risks and optimize the capital structure of the company. Through disciplined fiscal management, the Chief Financial Officer supports the ongoing commitment to innovation and sustainability, ensuring that the financial resources of the company remain aligned with the core mission of delivering high-quality plant-based ingredients to diverse global markets.

Li Ng, the Chief Financial Officer, Greater (Asia) at Roquette, directs all financial operations and fiscal strategy across the rapidly expanding Asian markets. Overseeing regional revenue growth and cost management, the Chief Financial Officer, Greater (Asia) ensures that local business units operate with maximum efficiency while adhering to international corporate standards. This leadership role involves navigating complex regulatory environments and currency fluctuations to protect the profitability of regional operations. By analyzing market-specific data, Li Ng identifies key investment opportunities that support the broader goal of increasing the footprint of the company in the health and nutrition sectors. The Chief Financial Officer, Greater (Asia) collaborates with global leadership to synchronize regional financial performance with the overarching corporate strategy. Through the development of localized financial models, the Chief Financial Officer, Greater (Asia) drives sustainable growth and operational stability, ensuring that the company maintains a strong competitive advantage throughout the Asian region.

Vincent Claps, the Vice President, Finance & Divisional Chief Financial Officer, Pharma Solutions at Roquette, manages the financial performance and strategic budgeting for the specialized pharmaceutical solutions division. Overseeing the cost structures associated with high-performance excipients and biopharmaceutical applications, the Vice President, Finance & Divisional Chief Financial Officer, Pharma Solutions ensures that research and development investments yield measurable returns. This role requires deep collaboration with the pharmaceutical product teams to align financial planning with the rigorous quality standards required for oral medicines and biopharmaceutical manufacturing. By optimizing the divisional budget, Vincent Claps supports the acceleration of innovation in the health sector. The Vice President, Finance & Divisional Chief Financial Officer, Pharma Solutions monitors the profitability of specific product lines to ensure long-term viability. Through precise financial oversight, the Vice President, Finance & Divisional Chief Financial Officer, Pharma Solutions enables the division to deliver critical ingredients that improve patient outcomes while maintaining the sustainability goals of the company.